Skip to main content

Table 6 Pharmacokinetic parameters of MLC in rabbit plasma after oral administration of MELFLAM tab (15 mg) tablets and Bulk drug (n = 6)

From: Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study

Pharmacokinetic parameter

Reference (mean ± SD)

Test (mean ± SD)

Geometric mean ratio of T/R (90% CI)a

P value

Cmaxa, μg mL−1

0.6577 ± 0.01

0.7792 ± 0.01

118.50% (115.21, 121.78)b

0.0002

Tmax, h

6.1 ± 0.36 (5.8–6.5)

4.0 ± 0.46 (3.5–4.4)

0.9853

T1/2, h

21.5261 ± 0.57

20.3629 ± 0.20

0.7709

AUC0-ta , μg h mL−1

17.3070 ± 0.29

19.7973 ± 1.06

114.57 (106.66, 122.47)b

0.0146

AUC0-∞a , μg h mL−1

25.2047 ± 0.67

25.1649 ± 0.89

100.09 (91.76, 108.41)b

0.9493

MRT, h

31.2453 ± 0.69

29.3837 ± 0.55

0.2436

Ke

0.0320 ± 0.01

0.0340 ± 0.01

0.4826

  1. a Bioequivalence criteria are defined as 90% CI of the geometric mean ratios of the test formulation/reference formulation lies between 80.00% and 125.00% for AUC0-t, AUC0-∞, and Cmax bStatistical calculations for AUC and Cmax were based on log-transformed data; c values in the bracket indicate with range (lowest Tmax – highest Tmax)